Position in BSX
as of Mar 31, 2026
· filed Apr 28, 2026
Position Value
$214,605
-$283,884 QoQ
Shares Held
3,420
-34.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in BSX Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Mar 31, 2026Kathmere Capital Management, LLC holds $25,913,153 across 7 Medical Devices names. BSX ranks #5 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GMED |
Globus Medical Inc
|
271,126 | $23,360,216 | |
| 2 | ABT |
Abbott Laboratories
|
7,644 | $784,809 | |
| 3 | MDT |
Medtronic plc
|
8,963 | $776,643 | |
| 4 | SYK |
Stryker Corp
|
1,625 | $533,958 | |
| 5 | BSX |
Boston Scientific Corp
This page
|
3,420 | $214,605 | |
| 6 | INMD |
InMode Ltd.
|
13,667 | $186,964 | |
| 7 | HYPR |
Hyperfine, Inc.
|
51,813 | $55,958 |
All Filings in BSX
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $214,605 | 3,420 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $498,489 | 5,228 | Shares | Sole | 2026-01-13 | |
| 2025-09-30 | $498,889 | 5,110 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $531,249 | 4,946 | Shares | Sole | 2025-07-16 | |
| 2025-03-31 | $479,280 | 4,751 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $402,833 | 4,510 | Shares | Sole | 2025-01-14 | |
| 2024-09-30 | $291,288 | 3,476 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $201,304 | 2,614 | Shares | Sole | 2024-08-15 | |
| No filing history on record for this holder in this stock. | ||||||